Author

Raphaelle Auguste

Observed institutions: National Institutes of Health, Jacobi Medical Center, National Institute of Allergy and Infectious Diseases, Rutgers New Jersey Medical School, Vaccine Research Center

OpenAlex ID: A5069263176

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants

2019 · Coleen K Cunningham, Elizabeth J McFarland, et al. · The Journal of Infectious Diseases · 62

Mental Health Diagnoses, Symptoms, and Service Utilization in US Youth with Perinatal HIV Infection or HIV Exposure

2019 · Renee Smith, Yanling Huo, et al. · AIDS Patient Care and STDs · 36

Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus–infected and Exposed, Uninfected Youth

2019 · Anna-Barbara Moscicki, Brad Karalius, et al. · Clinical Infectious Diseases · 31

Healthcare Transition Outcomes Among Young Adults With Perinatally Acquired Human Immunodeficiency Virus Infection in the United States

2019 · Katherine Tassiopoulos, Yanling Huo, et al. · Clinical Infectious Diseases · 30

Salivary metabolite levels in perinatally HIV-infected youth with periodontal disease

2020 · Fabian Schulte, Oliver D. King, et al. · Metabolomics · 15

Works count: 5

Citation count: 174

H-index: 5

I10-index: 5